P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

November 2012

Features

Editorial

Reinventing the Pharmacy and Therapeutics Committee

As value-based reimbursement and accountable-care models drive us into an era of cost-containment and care-management strategies, the P&T committee must reinvent itself.
David Shulkin, MD

Health Care & Law

Accountable Care Organizations

An Improvement Over HMOs?

The ACO model is considered an important achievement of health care reform legislation. However, ACOs might not be able to deliver on their promises in part because of the slowly recovering economy. It is also not clear how much money will be saved, and not all hospitals plan to participate.
Rita M. Marcoux, RPh, MBA; E. Paul Larrat, RPh, PhD; and F. Randy Vogenberg, RPh, PhD

The Nanomedicine Revolution

Part 3: Regulatory and Safety Challenges

Before the FDA can set up safety guidelines for nanomedicines, it needs to establish valid testing criteria. The goal is to strike a balance between underregulation (which can lead to questionable approvals) and overregulation (which can inhibit innovation).
C. Lee Ventola, MS

Implementation of Management Guidelines For Chronic Myeloid Leukemia

Perspectives in the United States

Twenty percent to 30% of CML patients are not being treated according to clinical practice guidelines. The authors review the most recent guidelines published by the National Comprehensive Cancer Network and the European LeukemiaNet.
David Rizzieri, MD; and Joseph O. Moore, MD

Departments

Medication Errors

Beware of Basal Opioid Infusions With Patient-Controlled Analgesia

Basal opioid infusions may raise the risk of respiratory depression when given with patient-controlled analgesia.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Pharmacists Hope to Bill Under New Medicare ā€˜Gā€™ Code

Payment Would Be for Transitional Care After Hospital Discharge

A new Medicare ‘G’ code for transitional care may help to reduce the number of hospital readmissions.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Pharmaceutical Approval Update

Bosutinib (Bosulif) tablets for chronic myelogenous leukemia; linaclotide (Linzess) for irritable bowel syndrome/constipation and chronic idiopathic constipation; and regorafenib (Stivarga) tablets for metastatic colorectal cancer
Marvin M. Goldenberg, PhD, RPh, MS